192 related articles for article (PubMed ID: 22388646)
1. Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis.
Tanaka Y
Curr Opin Rheumatol; 2012 May; 24(3):319-26. PubMed ID: 22388646
[TBL] [Abstract][Full Text] [Related]
2. Is it possible to withdraw biologics from therapy in rheumatoid arthritis?
Tanaka Y; Hirata S
Clin Ther; 2013 Dec; 35(12):2028-35. PubMed ID: 24290736
[TBL] [Abstract][Full Text] [Related]
3. Next stage of RA treatment: is TNF inhibitor-free remission a possible treatment goal?
Tanaka Y
Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii124-7. PubMed ID: 23253919
[TBL] [Abstract][Full Text] [Related]
4. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
5. Current concepts in the management of rheumatoid arthritis.
Tanaka Y
Korean J Intern Med; 2016 Mar; 31(2):210-8. PubMed ID: 26932398
[TBL] [Abstract][Full Text] [Related]
6. Stopping tumour necrosis factor-targeted biological DMARDs in rheumatoid arthritis.
Tanaka Y
Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii15-ii22. PubMed ID: 27856656
[TBL] [Abstract][Full Text] [Related]
7. [The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part I. Tumor necrosis factor alpha inhibitors].
Swierkot J; Madej M
Pol Merkur Lekarski; 2011 Apr; 30(178):283-8. PubMed ID: 21595176
[TBL] [Abstract][Full Text] [Related]
8. Innovative treatment strategies for patients with rheumatoid arthritis.
van der Kooij SM; Allaart CF; Dijkmans BA; Breedveld FC
Curr Opin Rheumatol; 2008 May; 20(3):287-94. PubMed ID: 18388520
[TBL] [Abstract][Full Text] [Related]
9. Biologics in rheumatoid arthritis.
Sharma PK; Hota D; Pandhi P
J Assoc Physicians India; 2004 Mar; 52():231-6. PubMed ID: 15636315
[TBL] [Abstract][Full Text] [Related]
10. Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study.
Lee SJ; Chang H; Yazici Y; Greenberg JD; Kremer JM; Kavanaugh A
J Rheumatol; 2009 Aug; 36(8):1611-7. PubMed ID: 19369454
[TBL] [Abstract][Full Text] [Related]
11. Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study.
Allaart CF; Breedveld FC; Dijkmans BA
J Rheumatol Suppl; 2007 Nov; 80():25-33. PubMed ID: 17985420
[TBL] [Abstract][Full Text] [Related]
12. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
Sesin CA; Bingham CO
Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
[TBL] [Abstract][Full Text] [Related]
13. Biologics in early rheumatoid arthritis.
de Vries-Bouwstra JK; Dijkmans BA; Breedveld FC
Rheum Dis Clin North Am; 2005 Nov; 31(4):745-62. PubMed ID: 16287595
[TBL] [Abstract][Full Text] [Related]
14. Biologic therapy for early rheumatoid arthritis: the latest evidence.
Castro-Rueda H; Kavanaugh A
Curr Opin Rheumatol; 2008 May; 20(3):314-9. PubMed ID: 18388524
[TBL] [Abstract][Full Text] [Related]
15. [Maintenance therapy for rheumatoid arthritis after remission following successful treatment using biologics].
Ichikawa N; Yamanaka H
Nihon Rinsho; 2007 Jul; 65(7):1293-8. PubMed ID: 17642246
[TBL] [Abstract][Full Text] [Related]
16. Current tumor necrosis factor-alpha inhibitor use is associated with a higher probability of remissions in patients with rheumatoid arthritis.
Liang GC; Cordero M; Dyer A; Chang RW
J Rheumatol; 2005 Sep; 32(9):1662-5. PubMed ID: 16142857
[TBL] [Abstract][Full Text] [Related]
17. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
Prescrire Int; 2010 Feb; 19(105):30-4. PubMed ID: 20455343
[TBL] [Abstract][Full Text] [Related]
18. TNF inhibitors for rheumatoid arthritis - a year in review.
Simsek I
Bull NYU Hosp Jt Dis; 2011; 69(3):220-4. PubMed ID: 22035432
[TBL] [Abstract][Full Text] [Related]
19. Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study.
Tanaka Y; Takeuchi T; Mimori T; Saito K; Nawata M; Kameda H; Nojima T; Miyasaka N; Koike T;
Ann Rheum Dis; 2010 Jul; 69(7):1286-91. PubMed ID: 20360136
[TBL] [Abstract][Full Text] [Related]
20. Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission.
Alivernini S; Peluso G; Fedele AL; Tolusso B; Gremese E; Ferraccioli G
Arthritis Res Ther; 2016 Feb; 18():39. PubMed ID: 26842890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
